AC
ADMS

Armistice Capital’s Adamas Pharmaceuticals ADMS Stock Holding History

Armistice Capital’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,000
Closed -$550K – 84
2017
Q3 		$550K Buy
+26,000
New +$477K 0.06% 64

Armistice Capital's ADMS Position: Q4 2021 in Review

Armistice Capital sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 4,000,000 shares — an estimated $19.6M sold.

Armistice Capital first reported a position in ADMS in Q4 2016 and held it in 16 quarters. The position peaked at $20.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

  • Armistice Capital reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Armistice Capital sold 4,000,000 Adamas Pharmaceuticals shares in Q4 2021, an estimated $19.6M.
  • Armistice Capital first reported a position in Adamas Pharmaceuticals in Q4 2016 and held it in 16 quarters.
  • Armistice Capital's Adamas Pharmaceuticals position peaked at $20.4M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.